Literature DB >> 23345292

Worrisome trend of new multiple mechanisms of linezolid resistance in staphylococcal clones diffused in Italy.

Floriana Campanile1, Gino Mongelli, Dafne Bongiorno, Chiara Adembri, Milva Ballardini, Marco Falcone, Francesco Menichetti, Antonella Repetto, Carla Sabia, Assunta Sartor, Claudio Scarparo, Carlo Tascini, Mario Venditti, Federica Zoppi, Stefania Stefani.   

Abstract

In order to assess the frequency of clinically relevant linezolid-resistant staphylococcal isolates, and the role of linezolid in maintaining and coselecting multiple resistance mechanisms (cfr, 23S rRNA, L3/L4 mutations), a prospective Italian study was performed from 2010 to 2011 to confirm the diffusion of three major multidrug-resistant clones (ST2, ST5, ST23).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23345292      PMCID： PMC3666802          DOI： 10.1128/JCM.00098-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Linezolid breakpoints.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2001-05       Impact factor: 8.067

2.  Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data.

Authors:  M Miragaia; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Bacteriol       Date:  2007-01-12       Impact factor: 3.490

3.  Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.

Authors:  R D Gonzales; P C Schreckenberger; M B Graham; S Kelkar; K DenBesten; J P Quinn
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

4.  Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients.

Authors:  S Ibrahem; S Salmenlinna; O Lyytikäinen; M Vaara; J Vuopio-Varkila
Journal:  Clin Microbiol Infect       Date:  2008-11       Impact factor: 8.067

5.  Clonality among multidrug-resistant hospital-associated Staphylococcus epidermidis in northern Europe.

Authors:  Micael Widerström; Tor Monsen; Carina Karlsson; Helén Edebro; Anders Johansson; Johan Wiström
Journal:  Scand J Infect Dis       Date:  2009

6.  Linezolid resistance in a clinical isolate of Staphylococcus aureus.

Authors:  S Tsiodras; H S Gold; G Sakoulas; G M Eliopoulos; C Wennersten; L Venkataraman; R C Moellering; M J Ferraro
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

7.  Identification of a plasmid-borne chloramphenicol-florfenicol resistance gene in Staphylococcus sciuri.

Authors:  S Schwarz; C Werckenthin; C Kehrenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates.

Authors:  Märit Pringle; Jacob Poehlsgaard; Birte Vester; Katherine S Long
Journal:  Mol Microbiol       Date:  2004-12       Impact factor: 3.501

9.  Molecular characterization of Staphylococcus epidermidis strains isolated from a teaching hospital in Shanghai, China.

Authors:  Min Li; Xing Wang; Qian Gao; Yuan Lu
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472

10.  Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.

Authors:  Jeffrey B Locke; Mark Hilgers; Karen Joy Shaw
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191
View more
  6 in total

1.  Mutations in the bacterial ribosomal protein l3 and their association with antibiotic resistance.

Authors:  Rasmus N Klitgaard; Eleni Ntokou; Katrine Nørgaard; Daniel Biltoft; Lykke H Hansen; Nicolai M Trædholm; Jacob Kongsted; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

2.  Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.

Authors:  Jamese J Hilliard; Vivekananda Datta; Christine Tkaczyk; Melissa Hamilton; Agnieszka Sadowska; Omari Jones-Nelson; Terrence O'Day; William J Weiss; Szabolcs Szarka; Vien Nguyen; Laszlo Prokai; JoAnn Suzich; C Kendall Stover; Bret R Sellman
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Characterization of Staphylococcus epidermidis clinical isolates from hospitalized patients with bloodstream infection obtained in two time periods.

Authors:  Verónica I Martínez-Santos; David A Torres-Añorve; Gabriela Echániz-Aviles; Isela Parra-Rojas; Arturo Ramírez-Peralta; Natividad Castro-Alarcón
Journal:  PeerJ       Date:  2022-10-04       Impact factor: 3.061

4.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

5.  A cfr-positive clinical staphylococcal isolate from India with multiple mechanisms of linezolid-resistance.

Authors:  Vineeth Rajan; Vijay Gowdara Shankarappa Kumar; Shubha Gopal
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

6.  Molecular epidemiology of coagulase-negative bloodstream isolates: detection of Staphylococcus epidermidis ST2, ST7 and linezolid-resistant ST23.

Authors:  Adrián Martínez-Meléndez; Rayo Morfín-Otero; Licet Villarreal-Treviño; Adrián Camacho-Ortíz; Gloria González-González; Jorge Llaca-Díaz; Eduardo Rodríguez-Noriega; Elvira Garza-González
Journal:  Braz J Infect Dis       Date:  2016-07-06       Impact factor: 3.257
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.